title: Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients.
authors.affiliation: Department of Medicine, University Hospital Nijmegen, The Netherlands.
authors.forename: A J
authors.initials: AJ
authors.lastname: Hoitsma
authors.forename: R G
authors.initials: RG
authors.lastname: Tiggeler
authors.forename: J F
authors.initials: JF
authors.lastname: Wetzels
authors.forename: J H
authors.initials: JH
authors.lastname: Berden
authors.forename: R A
authors.initials: RA
authors.lastname: Koene
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage*; D001794:Blood Pressure; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation
chemical_list: D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine